Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001328969 | SCV001520239 | uncertain significance | Cerebral palsy, spastic quadriplegic, 3 | 2020-06-03 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Ambry Genetics | RCV004035658 | SCV003698384 | uncertain significance | not specified | 2021-09-16 | criteria provided, single submitter | clinical testing | The c.1372G>A (p.G458R) alteration is located in exon 10 (coding exon 9) of the ADD3 gene. This alteration results from a G to A substitution at nucleotide position 1372, causing the glycine (G) at amino acid position 458 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |